Showing results (31-40 of 97) with videos related to
Sort By:
Pageof 10
Lancet (London, England)|January 3, 2016
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysisDena Ettehad, Connor A Emdin, Amit Kiran, et al.Anaesthesia|January 14, 2026
Measurement and management of adult blood pressure in the peri-operative period: updated guidelines from the Association of Anaesthetists and the British and Irish Hypertension SocietyTerry McCormack, Alex Wickham, Sinéad T J McDonagh, et al.Research Square|March 18, 2024
Faith-based leaders' perceptions on the implementation of programs to promote healthy lifestyles in churches in Barbados-a mixed-methods analysisNatasha Sobers, Madhuvanti Murphy, Saria Hassan, et al.International Journal of Clinical Practice|May 21, 2020
The treatment rate of erectile dysfunction (ED) in younger men with type 2 diabetes is up to four times higher than the equivalent non-diabetes populationMike Stedman, Martin B Whyte, Mark Lunt, et al.European Heart Journal|December 20, 2015
Bivalirudin, glycoprotein inhibitor, and heparin use and association with outcomes of primary percutaneous coronary intervention in the United KingdomAlex Sirker, Mamas Mamas, Derek Robinson, et al.BMC Public Health|July 3, 2025
Faith-based leaders' perceptions on the implementation of programs to promote healthy lifestyles in churches in Barbados- a mixed-methods analysisNatasha P Sobers, Madhuvanti Murphy, Saria Hassan, et al.JACC. Cardiovascular Interventions|January 25, 2015
Access site practice and procedural outcomes in relation to clinical presentation in 439,947 patients undergoing percutaneous coronary intervention in the United kingdomKarim Ratib, Mamas A Mamas, Simon G Anderson, et al.Nutrients|September 9, 2022
The Impact of Nutrition-Based Interventions on Nutritional Status and Metabolic Health in Small Island Developing States: A Systematic Review and Narrative SynthesisEden Augustus, Emily Haynes, Cornelia Guell, et al.Heart (British Cardiac Society)|July 29, 2016
Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortalitySimon G Anderson, David C Hutchings, Mark Woodward, et al.Cardiovascular Endocrinology & Metabolism|December 26, 2025
Pulse wave velocity is elevated in people with serious mental illness with vascular age advanced in two-thirds of individualsAdrian H Heald, Sangeeth Veluchamy, Karen Barchetti, et al.Pageof 10